Rigel Pharmaceuticals
RIGL
RIGL
120 hedge funds and large institutions have $168M invested in Rigel Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $248M → $168M (-$79.7M)
Holders
120
Holding in Top 10
1
Calls
$27K
Puts
–
Top Buyers
| 1 | +$3.36M | |
| 2 | +$2.25M | |
| 3 | +$2.19M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.59M |
| 5 |
PC
Paulson & Co
New York
|
+$980K |
Top Sellers
| 1 | -$9.47M | |
| 2 | -$5.86M | |
| 3 | -$3.47M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.04M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$864K |